E-LIB Suche - Ergebnisse für: Koomen, Jeroen V.

1

Infliximab in paediatric inflammatory bowel disease: Extern..:

Heikal, Omnia Salah ; van Rheenen, Patrick F. ; Touw, Daan J....
British Journal of Clinical Pharmacology. , 2024

Link: https://doi.org/10.1111/..

2

A Joint Pharmacokinetic Model for the Simultaneous Descript..:

Koomen, Jeroen V. ; Knobbe, Tim J. ; Zijp, Tanja R....
Clinical Pharmacokinetics. 62 (2023) 8 - p. 1117-1128 , 2023

Link: https://doi.org/10.1007/..

3

Pharmacodynamic mechanism-based interaction model for the h..:

Su, Hong ; Koomen, Jeroen V. ; Eleveld, Douglas J...
British Journal of Anaesthesia. 131 (2023) 2 - p. 222-233 , 2023

Link: https://doi.org/10.1016/..

4

Exposure–Response Analysis of the Sodium–Glucose Cotranspor..:

van der Hoek, Sjoukje ; Koomen, Jeroen V. ; van Bommel, Erik J. M....
Journal of Personalized Medicine. 13 (2023) 5 - p. 747 , 2023

Link: https://doi.org/10.3390/..

5

Urinary Biomarkers in a Living Donor Kidney Transplantation..:

Huisman, G. J. Julia ; Spraakman, Nora A. ; Koomen, Jeroen V....
International Journal of Molecular Sciences. 24 (2023) 6 - p. 5649 , 2023

Link: https://doi.org/10.3390/..

6

Organic Anion Transporter Gene Variants Associated With Pla..:

Smeijer, J. David ; Koomen, Jeroen V. ; Kohan, Donald E....
Clinical Pharmacology & Therapeutics. 112 (2022) 5 - p. 1098-1107 , 2022

Link: https://doi.org/10.1002/..

7

Optimising the Nadroparin Dose for Thromboprophylaxis Durin..:

Jaspers, Tessa C. C. ; Meijer, Charlotte E. ; Vleming, Louis Jean...
Clinical Pharmacokinetics. 61 (2022) 11 - p. 1559-1569 , 2022

Link: https://doi.org/10.1007/..

8

Evaluation of the Pharmacokinetics and Exposure–Response Re..:

van der Aart-van der Beek, Annemarie B. ; Koomen, Jeroen V. ; Dekkers, Claire C. J....
Clinical Pharmacokinetics. 60 (2021) 4 - p. 517-525 , 2021

Link: https://doi.org/10.1007/..

9

Individual Atrasentan Exposure is Associated With Long‐term..:

Koomen, Jeroen V. ; Stevens, Jasper ; Bakris, George...
Clinical Pharmacology & Therapeutics. 109 (2021) 6 - p. 1631-1638 , 2021

Link: https://doi.org/10.1002/..

10

A Review of the Dose Justification of Phase 3 Trials to Reg..:

Koomen, Jeroen V. ; Stevens, Jasper ; Monster-Simons, Margje H...
Frontiers in Pharmacology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

11

Inter‐individual variability in atrasentan exposure partly ..:

Koomen, Jeroen V. ; Stevens, Jasper ; Bakris, George...
Diabetes, Obesity and Metabolism. 23 (2020) 2 - p. 561-568 , 2020

Link: https://doi.org/10.1111/..

12

Exposure–response relationships of dapagliflozin on cardior..:

Koomen, Jeroen V. ; Stevens, Jasper ; Heerspink, Hiddo J.L.
British Journal of Clinical Pharmacology. 86 (2020) 11 - p. 2192-2203 , 2020

Link: https://doi.org/10.1111/..

13

Exposure–response relationships for the sodium‐glucose co‐t..:

Kroonen, Marjolein Y. A. M. ; Koomen, Jeroen V. ; Petrykiv, Sergei I....
Diabetes, Obesity and Metabolism. 22 (2020) 6 - p. 916-921 , 2020

Link: https://doi.org/10.1111/..

14

Exposure and response analysis of aleglitazar on cardiovasc..:

Koomen, Jeroen V. ; Heerspink, Hiddo J. L. ; Schrieks, Ilse C....
Diabetes, Obesity and Metabolism. 22 (2019) 1 - p. 30-38 , 2019

Link: https://doi.org/10.1111/..

15

Determining the optimal dose of atrasentan by evaluating th..:

Koomen, Jeroen V. ; Stevens, Jasper ; Mostafa, Nael M....
Diabetes, Obesity and Metabolism. 20 (2018) 8 - p. 2019-2022 , 2018

Link: https://doi.org/10.1111/..